271 related articles for article (PubMed ID: 32146654)
21. Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases.
Huang Y; Yin Y; Zhou W
Front Endocrinol (Lausanne); 2021; 12():640565. PubMed ID: 33746905
[TBL] [Abstract][Full Text] [Related]
22. Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: A propensity score matching analysis.
Yan T; Qiu W; Song J; Ying T; Fan Y; Yang Z
Clin Endocrinol (Oxf); 2021 Jul; 95(1):209-216. PubMed ID: 33660317
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
[TBL] [Abstract][Full Text] [Related]
24. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
25. [Risk Factors of Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma:An Analysis Based on Data from the Surveillance, Epidemiology and End Results Database].
Zheng KS; Zeng Y; Chen C; Wu YZ; Chen B; Ying WB; Zheng KW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):736-743. PubMed ID: 30606382
[TBL] [Abstract][Full Text] [Related]
26. Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients.
Song RY; Kim HS; Kang KH
World J Surg Oncol; 2022 May; 20(1):170. PubMed ID: 35643530
[TBL] [Abstract][Full Text] [Related]
27. Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma.
Zhao H; Hu J; Cui L; Gong Y; Huang T
Front Endocrinol (Lausanne); 2023; 14():1164069. PubMed ID: 37720525
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients.
Zheng X; Peng C; Gao M; Zhi J; Hou X; Zhao J; Wei X; Chi J; Li D; Qian B
Cancer Biol Med; 2019 Feb; 16(1):121-130. PubMed ID: 31119052
[TBL] [Abstract][Full Text] [Related]
29. The analysis of clinicopathologic predictors of lymph node metastasis and postoperative recurrence in patients with papillary thyroid microcarcinoma from Guangdong Province, China-a multicenter retrospective study.
He LY; Chen ML; Wang WW; Balde AI; Li Z; Cai Z; Han S; Lei ST; Zhou MW; Zhang GQ
Int J Clin Exp Pathol; 2017; 10(9):9735-9743. PubMed ID: 31966856
[TBL] [Abstract][Full Text] [Related]
30. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
[TBL] [Abstract][Full Text] [Related]
31. [Risk Factors for central lymph node metastasis in 1 988 papillary thyroid microcarcinoma patients].
Li XJ; Yang L; Ma BL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(1):52-57. PubMed ID: 29774686
[No Abstract] [Full Text] [Related]
32. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
Lin KL; Wang OC; Zhang XH; Dai XX; Hu XQ; Qu JM
Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
[TBL] [Abstract][Full Text] [Related]
33. Predictive Factors for Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Ann Surg Oncol; 2016 Sep; 23(9):2866-73. PubMed ID: 27075321
[TBL] [Abstract][Full Text] [Related]
34. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
35. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
36. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M
Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
Kim WY; Kim HY; Son GS; Bae JW; Lee JB
J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
[TBL] [Abstract][Full Text] [Related]
38. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases.
Medas F; Canu GL; Cappellacci F; Boi F; Lai ML; Erdas E; Calò PG
Front Endocrinol (Lausanne); 2020; 11():551. PubMed ID: 32982963
[No Abstract] [Full Text] [Related]
39. Hashimoto's thyroiditis is negatively associated with lymph node metastasis in PTMC.
Huang H; Xu S; Ni S; Liu W; Liu S
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15525-15533. PubMed ID: 37646829
[TBL] [Abstract][Full Text] [Related]
40. Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.
Lin DZ; Qu N; Shi RL; Lu ZW; Ji QH; Wu WL
Onco Targets Ther; 2016; 9():5307-16. PubMed ID: 27601922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
